Clinical Trials Browser

Phase 1/2 × Has results × tebentafusp × Clear all

NCT02570308 2023-03-21

A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma

Phase 1/2 Completed

146 enrolled 26 charts

Uveal Melanoma, Melanoma